Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Investors: Take Advantage of Double Fed Tax Credits on Critical Minerals Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Titan Pharmaceuticals Inc
TTNP
Healthcare
Titan Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in developing therapeutics utilizing its long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. Its ProNeura continuous drug delivery system consists of a small, solid rod-shaped implant made from a mixture of ethylene-vinyl acetate (EVA), and a drug substance. Its first product...
, Probuphine (buprenorphine implant), is based on ProNeura technology, which is used for the maintenance treatment of opioid use disorder in clinically stable patients taking 8 milligrams (mg) or less a day of oral buprenorphine. Its product pipeline includes the Kappa Opioid Receptor Agonist (TP-2021) Implant and Nalmefene Implant. Its TP-2021 is used for the treatment of moderate-to-severe chronic pruritus. Its Nalmefene Implant is used for the prevention of relapse in opioid use disorder (OUD) patients following detoxification from opioids.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:TTNP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
KennyH
X
Post by
KennyH
on Dec 10, 2021 1:47am
FSD Pharma Establishes New Regulatory Advisory Board
FSD Pharma Establishes New Regulatory Advisory Board with the Appointment of Joga Gobburu, Ph.D., and Mary Melnyk, Ph.D., as Members Regulatory Advisory Board will oversee the drug development
...more
(0)
•••
KennyH
X
Post by
KennyH
on Dec 06, 2021 9:44pm
H.C. Wainwright 2nd Annual Psychedelics Virtual Conference
FSD Pharma to Present at the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD
...more
(0)
•••
KennyH
X
Post by
KennyH
on Dec 03, 2021 11:12pm
FSD Pharma at the H.C. Wainwright 2nd Annual Psychedelics
FSD Pharma to Present at the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD
...more
(0)
•••
KennyH
X
Post by
KennyH
on Dec 03, 2021 2:15am
FSD Pharma: Demonstrating the Positive Effects of Lucid-MS
FSD Pharma Unveils Videos Demonstrating Positive Effects of
...more
(0)
•••
KennyH
X
Post by
KennyH
on Dec 01, 2021 7:58pm
📰📣iMining Technologies Launches Concierge Service📢📣📣
↓↓↓↓↓↓↓↓↓↓↓↓↓Click the link for the Full Details of the Article: ↓↓↓↓↓↓↓↓↓↓↓↓↓ BitBit Financial Inc., a wholly owned subsidiary of iMining Technologies Inc., has set-up concierge
...more
(0)
•••
KennyH
X
Post by
KennyH
on Nov 26, 2021 10:54pm
🎥📰Anthony Durkacz on Building a Turnaround at FSD Pharma📣
(0)
•••
KennyH
X
Post by
KennyH
on Nov 23, 2021 7:48pm
📰📣Anthony Durkacz on Building a Turnaround at FSD Pharma🎥
(668)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jan 22, 2020 11:06am
steady at this point
it's doing well so far glta shareholders.
(668)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jan 21, 2020 10:39am
it's time to go up again
so glta shareholders.
(668)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jan 03, 2020 6:15pm
still holding this stock
it is steadily climbing up for shareholders,so glta.
(668)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jan 03, 2020 10:32am
added more of this one
this morning to increase my leverage,so glta shareholders.
(668)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Dec 30, 2019 11:39am
TTNP titan pharmaceuticals
is the correct symbol.
(668)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Dec 30, 2019 11:29am
it's a buy today for me finally after
watching it since last spring,it was time to get onboard this one at .21 cents per share,so glta.
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
AI Beyond Hype: Real-world Applications and Possibilities
Gander Gold Discovers Significant Gold System at Lizard Pond Claims – Gander South Project